466
Z.-P. Hu et al. / Tetrahedron: Asymmetry 23 (2012) 461–467
4.2.9. (S)-Ethyl 2-amino-4,5,6-triphenyl-4H-pyran-3-carboxyl-
by HPLC with a CHIRALCEL AD-H column (i-PrOH/hexane = 10:90,
254 nm, 0.8 mL/min), tR (major) = 6.2 min, tR (minor) = 5.6 min,
12% ee.
ate 4i
Colorless oil. ½a D20
ꢁ
¼ þ22:1 (c 0.068, CHCl3); 1H NMR (400 MHz,
CDCl3): d = 7.28–7.16 (m, 10H), 7.09–7.07 (m, 3H), 6.85 (d,
J = 7.4 Hz, 2H), 6.19 (br s, 2H), 4.53 (s, 1H), 4.07 (q, J = 6.8 Hz,
2H), 1.21 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3):
d = 169.12, 160.07, 145.93, 144.27, 138.72, 133.63, 129.54,
128.99, 128.35, 128.29, 128.07, 128.04, 127.79, 126.86, 126.22,
119.69, 80.03, 59.38, 44.09, 14.33; IR (KBr): 3458, 3328, 2960,
2928, 2852, 1674, 1636, 1598, 1495, 1445, 1408, 1257, 1231,
1148, 862, 748, 698 cmꢀ1; MS (ESI): m/z = 398.2 [M+H]+; HRMS
4.2.14. (R)-2-Amino-5-benzoyl-6-methyl-4-phenyl-4H-pyran-3-
carbonitrile 4o25
White solid, ½a 2D0
¼ ꢀ54:0 (c 0.100, CHCl3); mp 143.2–145.9 °C.
ꢁ
1H NMR (400 MHz, CDCl3): d = 7.57 (d, J = 7.5 Hz, 2H), 7.53–7.41
(m, 2H), 7.41–7.29 (m, 2H), 7.29–7.19 (m, 2H), 7.15 (t, J = 7.8 Hz,
2H), 4.62 (s, 2H), 4.59 (s, 1H), 1.79 (s, 3H); 13C NMR (100 MHz,
CDCl3): d = 195.83, 158.44, 148.71, 141.91, 137.74, 133.09,
128.73, 128.70, 128.63, 127.76, 127.45, 115.18, 60.84, 40.71,
18.04; MS (ESI): m/z = 317.1 [M+H]+; Enantiomeric excess was
determined by HPLC with a CHIRALCEL AD-H column (i-PrOH/hex-
ane = 10:90, 254 nm, 0.8 mL/min), tR (major) = 14.2 min, tR (min-
or) = 19.2 min, 29% ee.
(ESI) calcd for C26H24NO3 [M+H]+: 398.1751, found: 398.1757;
+
Enantiomeric excess was determined by HPLC with a CHIRALCEL
OD-H column (i-PrOH/hexane = 4:96, 254 nm, 0.5 mL/min), tR (ma-
jor) = 20.5 min, tR (minor) = 18.7 min, 87% ee.
4.2.10. (S)-2-Amino-6-methyl-4,5-diphenyl-4H-pyran-3-carbo-
nitrile 4k
4.2.15. (S)-2-Amino-4-phenyl-5,6-dihydro-4H-benzo[h] chrom-
White solid, ½a 2D0
ꢁ
¼ ꢀ65:4 (c 0.130, CHCl3); mp 129.0–132.0 °C.
ene-3-carbonitrile 4p6
1H NMR (400 MHz, CDCl3): d = 7.23–7.13 (m, 6H), 7.09–7.07 (m,
2H), 6.90–6.87 (m, 2H), 4.49 (s, 2H), 4.18 (s, 1H), 1.80 (s, 3H); 13C
NMR (100 MHz, CDCl3): d = 159.14, 142.98, 142.91, 137.51,
129.05, 128.37, 128.13, 127.87, 127.11, 126.97, 119.79, 115.05,
60.97, 44.20, 16.58; IR (KBr): 3464, 3348, 2924, 2189, 1699,
1642, 1598, 1562, 1403, 1168, 1067, 861, 795 cmꢀ1; MS (ESI): m/
z = 289.1 [M+H]+; HRMS (ESI) calcd for C19H17N2O+ [M+H]+:
289.1355, found: 289.1345; Enantiomeric excess was determined
by HPLC with a CHIRALCEL OD-H column (i-PrOH/hexane = 10:90,
254 nm, 0.8 mL/min), tR (major) = 9.6 min, tR (minor) = 14.3 min,
82% ee.
Yellow solid, ½a D20
¼ ꢀ44:0 (c 0.092, CHCl3); mp 174.0–177.9 °C.
ꢁ
1H NMR (400 MHz, CDCl3): d = 7.46 (d, J = 6.9 Hz, 1H), 7.40–7.16
(m, 7H), 7.11 (d, J = 7.1 Hz, 1H), 4.55 (s, 2H), 4.08 (s, 1H), 2.86–
2.63 (m, 2H), 2.22–2.14 (m, 1H), 2.10–2.02 (m, 1H); MS (ESI): m/
z = 301.1 [M+H]+; Enantiomeric excess was determined by HPLC
with a CHIRALCEL OD-H column (i-PrOH/hexane = 10:90, 254 nm,
0.8 mL/min), tR (major) = 15.5 min, tR (minor) = 18.7 min, 88% ee.
Acknowledgements
Financial supports from the National Natural Science Founda-
tion of China (Nos. 20972195, 21172270) and the Guangdong Engi-
neering Research Center of Chiral Drugs are gratefully
acknowledged.
4.2.11. (S)-2-Amino-5-methyl-4,6-diphenyl-4H-pyran-3-carbo-
nitrile 4l
Colorless oil. ½a D20
ꢁ
¼ þ11:6 (c 0.086, CHCl3); 1H NMR (400 MHz,
CDCl3): d = 7.41–7.27 (m, 10H), 4.41 (s, 2H), 3.99 (s, 1H), 1.58 (s,
3H); 13C NMR (100 MHz, CDCl3): d = 159.38, 143.28, 142.77,
133.08, 128.80, 128.72, 128.13, 127.79, 127.31, 120.24, 110.33,
59.79, 44.38, 16.84; IR (KBr): 3462, 3344, 2928, 2196, 1698,
1646, 1596, 1459, 1405, 1168, 1068, 859, 796 cmꢀ1; MS (ESI): m/
z = 289.1 [M+H]+; HRMS (ESI) calcd for C19H16N3NaO+ [M+Na]+:
311.1155, found: 311.1147; Enantiomeric excess was determined
by HPLC with a CHIRALCEL OD-H column (i-PrOH/hexane = 10:90,
254 nm, 0.8 mL/min), tR (major) = 11.4 min, tR (minor) = 16.8 min,
95% ee.
References
1. For the general reviews on organocatalysis, see: (a) Enantioselective
Organocatalyzed Reactions; Mahrwald, R., Ed.; Springer: Heidelberg, 2011.
Vols. I and II; (b) Vesely, J.; Rios, R. Curr. Org. Chem. 2011, 15, 4046; (c)
Bertelsen, S.; Jørgensen, K. A. Chem. Soc. Rev. 2009, 36, 2178; (d) Dondoni, A.;
Massi, A. Angew. Chem., Int. Ed. 2008, 47, 4638; (e) Dalko, P. I. Enantioselective
Organocatalysis; Wiley-VCH: Weinheim, 2007; (f) Pellissier, H. Tetrahedron
2007, 63, 9267; (g) Guillena, G.; Nájera, C.; Ramón, D. J. Tetrahedron: Asymmetry
2007, 18, 2249.
2. For reviews on organocatalytic asymmetric conjugate additions, see: (a)
Organocatalytic Enantioselective Conjugate Addition Reactions. A Powerful Tool
for the Stereocontrolled Synthesis of Complex Molecules; Vicario, J. L., Badia, D.,
Carrillo, L., Reyes, E., Eds.; RSC: Cambridge, 2010; (b) Roca-Lopez, D.; Sadaba,
D.; Delso, I.; Herrera, R. P.; Tejero, T.; Merino, P. Tetrahedron: Asymmetry 2010,
21, 2561; (c) Jautze, S.; Peters, R. Synthesis 2010, 365; (d) Almasßi, D.; Alonso, D.
A.; Nájera, C. Tetrahedron: Asymmetry 2007, 18, 299; (e) Tsogoeva, S. B. Eur. J.
Org. Chem. 2007, 11, 1701; (f) Sulzer-Mossé, S.; Alexakis, A. Chem. Commun.
2007, 3123; (g) Vicario, J. L.; Badía, D.; Carrillo, L. Synthesis 2007, 2065.
3. For reviews on organocatalytic cascade reactions, see: (a) Grondal, C.; Jeanty,
M.; Enders, D. Nat. Chem. 2010, 2, 167; (b) Alba, A. N.; Companyo, X.; Viciano,
M.; Rios, R. Curr. Org. Chem. 2009, 13, 1432; (c) Enders, D.; Grondal, C.; Hüettl,
M. R. M. Angew. Chem., Int. Ed. 2007, 46, 1570.
4. For examples of organocatalytic asymmetric conjugate additions of
malononitrile to enones, see: (a) Yang, W.; Jia, Y.; Du, D. M. Org. Biomol.
Chem. 2012, 10, 332; (b) Su, Z.; Lee, H. W.; Kim, C. K. Org. Biomol. Chem. 2011, 9,
6402; (c) Russo, A.; Capobianco, A.; Perfetto, A.; Lattanzi, A.; Peluso, A. Eur. J.
Org. Chem. 1922, 2011; (d) Shi, J.; Wang, M.; He, L.; Zheng, K.; Liu, X. H.; Lin, L.
L.; Feng, X. M. Chem. Commun. 2009, 4711; (e) Russo, A.; Perfetto, A.; Lattanzi,
A. Adv. Synth. Catal. 2009, 351, 3067; (f) Oliva, C. G.; Silva, A. M. S.; Resende, D. I.
S. P.; Paz, F. A. A.; Cavaleiro, J. A. S. Eur. J. Org. Chem. 2010, 3449; (g) Li, X. F.;
Cun, L. F.; Lian, C. X.; Zhong, L.; Chen, Y. C.; Liao, J.; Zhu, J.; Deng, J. G. Org.
Biomol. Chem. 2008, 6, 349; (h) Inokuma, T.; Hoashi, Y.; Takemoto, Y. J. Am.
Chem. Soc. 2006, 128, 9413; (i) Hoashi, Y.; Okino, T.; Takemoto, Y. Angew. Chem.,
Int. Ed. 2005, 44, 4032.
4.2.12. (R)-Ethyl 6-amino-5-cyano-2,4-diphenyl-4H-pyran-3-
carboxylate 4m23
White solid, ½a 2D0
¼ ꢀ7:5 (c 0.106, CHCl3); mp 169.3–172.5 °C.
ꢁ
1H NMR (400 MHz, CDCl3): d = 7.46–7.37 (m, 5H), 7.35–7.30 (m,
4H), 7.26–7.23 (m, 1H), 4.60 (s, 1H), 4.53 (s, 2H), 3.82 (q,
J = 7.1 Hz, 2H), 0.80 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3):
d = 165.81, 158.07, 154.41, 142.94, 133.17, 130.01, 128.73,
128.50, 128.07, 127.68, 127.45, 118.71, 109.79, 62.06, 60.72,
39.85, 13.36; MS (ESI): m/z = 347.1 [M+H]+; Enantiomeric excess
was determined by HPLC with a CHIRALCEL AD-H column (i-
PrOH/hexane = 10:90, 254 nm, 0.8 mL/min), tR (major) = 12.4 min,
tR (minor) = 19.9 min, 5% ee.
4.2.13. (S)-2-Amino-4,6-diphenyl-4H-pyran-3,5-dicarbonitrile
4n24
White solid, ½a 2D0
ꢁ
¼ þ1:8 (c 0.112, CHCl3); mp 60.0–63.3 °C. 1H
5. Zhao, S. L.; Zheng, C. W.; Zhao, G. Tetrahedron: Asymmetry 2009, 20, 1046.
6. Ren, Q.; Gao, Y. J.; Wang, J. Chem. Eur. J. 2010, 16, 13594.
7. Li, X. M.; Wang, B.; Zhang, J. M.; Yan, M. Org. Lett. 2011, 13, 374.
8. Hu, Z. P.; Lou, C. L.; Wang, J. J.; Chen, C. X.; Yan, M. J. Org. Chem. 2011, 76, 3797.
9. For reviews on 2-amino-4H-pyrans, see: (a) Geen, G. R.; Evans, J. M.; Vong, A. K.
In Comprehensive Heterocyclic Chemistry II; Katritzky, R. K. A. R., Rees, C. W., Eric,
NMR (400 MHz, CDCl3): d = 7.75 (d, J = 7.3 Hz, 2H), 7.57–7.32 (m,
8H), 4.82 (s, 2H), 4.35 (s, 1H); 13C NMR (100 MHz, CDCl3):
d = 157.80, 157.63, 140.56, 131.80, 129.82, 129.21, 128.73,
128.47, 127.78, 127.75, 117.79, 116.89, 90.88, 60.23, 40.73; MS
(ESI): m/z = 300.1 [M+H]+; Enantiomeric excess was determined